Business
Deloitte Names Kneat Ireland's Third Fastest Growing Technology Company
Deloitte Names Kneat Ireland's Third Fastest Growing Technology Company Canada ...
About this update from Kneat.com, Inc.
[{"type":"text","content":"\n \n \n \n Deloitte Names Kneat Ireland's Third Fastest Growing Technology Company\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n LIMERICK,\n \n Ireland\n \n ,\n \n Dec. 9, 2021\n \n /CNW/ -\n \n kneat.com, inc.\n \n (TSX: KSI)\n \n (\"Kneat or the Company\")\n \n \n a leader in digitizing and automating validation and quality processes,\n \n \n \n \n is pleased to announce it has been ranked 3\n \n rd\n \n in the prestigious 2021 Deloitte Ireland Technology Fast 50 list.\n \n \n \n \n \n \n \n \n \n \n The Deloitte Technology Fast 50 Awards is one of\n \n Ireland's\n \n foremost technology award programs. With Kneat's operational headquarters in Limerick,\n \n Ireland\n \n , the Company was included in the ranking of the country's 50 fastest growing technology companies, based on revenue growth over four years up until December 2020.  Over this period, Kneat recorded growth of 1,661%, whilst headcount increased 350%.\n \n \n In addition to placing third overall, Kneat was also awarded runner up for the Scale-Up Award, given to companies that have demonstrated an impressive ability to scale up and expand overseas.\n \n \n \"We are delighted with these awards and to be shortlisted with so many other exceptional companies. We would like to thank Deloitte, our customers, partners, shareholders, and our outstanding high performing global teams\", said\n \n Eddie Ryan\n \n , Chief Executive Officer of Kneat. \"It makes our team very proud that among our many clients we are assisting seven of the world's top 10 pharmaceutical companies and three of the world's leading COVID-19 vaccine manufacturers deliver their medicines to the highest quality standards\", continued Ryan.\n \n \n This award closes off a year which included several milestones such as a public equity funding round of over\n \n $20 million\n \n CAD in April, the continued acquisition and expansion of top biopharmaceutical clients, record-setting revenue growth achievements and the Company's recent uplisting to the Toronto Stock Exchange.\n \n \n Read more about Kn...